Morgan Stanley
-
-
-
-
-
-
-
5 takeaways from Moderna's investor day
-
-
-
-
-
-
-
Morgan Stanley Comments on Moderna (MRNA) Collaboration with OpenAI
-
-
-
-
-
-
-
Moderna (MRNA) stock up 7% after RSV vaccine candidate met targets, analysts positive
-
-
-
-
-
-
-
Moderna to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
-
-
-
-
-
-
-
Pre-Open Stock Movers 01/26: (MAT) (DKNG) (MSFT) Higher; (TYME) (FFIV) (NAVI) Lower (more...)
-
-
-
-
-
-
-
Moderna (MRNA) Flu Data Could Drive Shares to mid-$300s - Morgan Stanley
-
-
-
-
-
-
-
Moderna (MRNA) PhII Booster Data Demonstrates Protection Against South African and Brazilian Variants - Morgan Stanley
-
226,551 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

